医薬品の開発に
「実りある」
患者・市民参画を育てる
Multi-stakeholder Co-creation
Social co-creation with patients and public
Inclusive and sustainable participation from diverse backgrounds
Equitable and reciprocal benefits
Ongoing opportunities for mutual learning – not just receiving support or making requests
Concrete actions
Robust planning to return value to society
Clinical Trial Ambassador Project
Empirical research 'Using PED as Evidence'
A pilot case study 'Building PED using metaverse'
Patient-focused clinical trial ecosystem
Supporting citizen science
Interdisciplinary Approach to Science
Empirical research activities that foster patient and public involvement (PPI)
A Focus on Societal Implementation
Consultation to implement PPI
We offer consultations on PPI
in medicines development and clinical research.
Our team—representing various professional backgrounds—works with
companies, researchers, healthcare providers, and patient groups
to help put PPI into practice.
Participation in PFMD's initiative
Patient engagement and patient experience data
Patient engagement in health technology assessment
Global clinical trials ecosystem
Co-hosted by 1st PEOF+ Asia Pacific in Manila in 2026.
A Global Perspective
Systematizing PPI through international collaboration
Our Milestones
2020 In Austria, Boehringer Ingelheim and European Patients' Academy on Therapeutic Innovation jointly launch the Clinical Trial Ambassador Project. The first training program for patient organizations is delivered.
2021 Bringing Patient Education to Japan - Boehringer Ingelheim Japan, together with multiple patient organizations and researchers, comes together to design the Japan version of the Clinical Trial Ambassador Project.
2022 Beyondanscending organizational boundaries - Pharmaceutical companies, patient organizations, and researchers collaborate across organizational boundaries to deliver the first Clinical Trial Ambassador Training. Six patient participants complete the program and become Clinical Trial Ambassadors.
2024 Expanding Innovation to Society - To enhance the public value and credibility of the initiative, the project is formalized as a non-profit organization. On April 25, YORIAILab is established as a general incorporated association.
2025 Towards a Co-creation Community - To further advance patient and public involvement in healthcare and drug development, activities expand beyond the Clinical Trial Ambassador Project to include education, awareness, collaboration with domestic and international partners, and research. To date, 52 patients and members of the public complete the Clinical Trial Ambassador Training.
April 25, 2026
YORIAILab has celebrated
its 2nd anniversary
News
2026.4.7
We have compiled a list of publicly accessible resources for learning about medicines development. Each resource is accompanied by information on its intended audience. This list was created as one of the outputs of the 2025 internship program.
-
List of Resources for Learning about Medicines Development (Japanese) ➡️
2026.4.7
We have compiled a list of publicly accessible resources for learning about medicines development. Each resource is accompanied by information on its intended audience. This list was created as one of the outputs of the 2025 internship program.
-
List of Resources for Learning about Medicines Development (Japanese) ➡️
2026.4.20
2026年度定時社員総会を6月23日（火）に開催（現地＋オンライン）いたします。特別会員ならびに一般会員のみなさま（一般社団法人法にもとづく議決権を有する社員となります）にはできる限りのご参加をお願いいたします。本年度は役員（理事）の改選年度になります。総会に続けて治験アンバサダー座談会「寄合」➡️（内容準備中）と交流会（現地のみ）を実施します。
2026.4.18
日本臨床試験学会シンポジウム（共催：CTX研究会）『日本におけるDCT推進の現状と課題～「ドラッグ/デバイスラグ・ロス」解消への貢献を考える！～』にて、「患者視点からのDCT－期待と課題」と題した発表をさせていただきました。本年2月と3月に治験アンバサダーのみなさん17名と実施したDCTワークショップの成果➡️を広く共有しました。
Public consultation
Public comment collection on new systems and guidelines regarding patient and citizen participation
We are currently soliciting public comments on the following new laws and systems. Anyone can submit their opinion.
If you have any questions, please contact us here: ✉ nobutaka.yagi@yoriailab.com
Events & Projects
Clinical Trial Ambassador Project
Highlights
New Resources ➡️
Meaningful Engagement
The discussion we presented at the Sequential Meetings - Consensus for Global Research Ethics and Meaningful Engagemen has been published in the December 2025 issue of Clinical Evaluation. YORIAILab endorses the Statement for Global REsearch Ethics Norm and Meaningful Engagement (GREEN Statement), which was adopted following a series of deliberations at the conference.
